These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 7991129)
1. Adult GM1 gangliosidosis: immunohistochemical and ultrastructural findings in an autopsy case. Yoshida K; Ikeda S; Kawaguchi K; Yanagisawa N Neurology; 1994 Dec; 44(12):2376-82. PubMed ID: 7991129 [TBL] [Abstract][Full Text] [Related]
2. An autopsy case of G Uchino A; Nagai M; Kanazawa N; Ichinoe M; Yanagisawa N; Adachi K; Nanba E; Ishiura H; Mitsui J; Tsuji S; Suzuki K; Murayama S; Nishiyama K Neuropathology; 2020 Aug; 40(4):379-388. PubMed ID: 32219895 [TBL] [Abstract][Full Text] [Related]
3. Type 3 GM1 gangliosidosis: characteristic MRI findings correlated with dystonia. Uyama E; Terasaki T; Watanabe S; Naito M; Owada M; Araki S; Ando M Acta Neurol Scand; 1992 Dec; 86(6):609-15. PubMed ID: 1336295 [TBL] [Abstract][Full Text] [Related]
4. GM1-gangliosidosis in American black bears: clinical, pathological, biochemical and molecular genetic characterization. Muthupalani S; Torres PA; Wang BC; Zeng BJ; Eaton S; Erdelyi I; Ducore R; Maganti R; Keating J; Perry BJ; Tseng FS; Waliszewski N; Pokras M; Causey R; Seger R; March P; Tidwell A; Pfannl R; Seyfried T; Kolodny EH; Alroy J Mol Genet Metab; 2014 Apr; 111(4):513-21. PubMed ID: 24581871 [TBL] [Abstract][Full Text] [Related]
5. Intravenous delivery of adeno-associated viral gene therapy in feline GM1 gangliosidosis. Gross AL; Gray-Edwards HL; Bebout CN; Ta NL; Nielsen K; Brunson BL; Lopez Mercado KR; Osterhoudt DE; Batista AR; Maitland S; Seyfried TN; Sena-Esteves M; Martin DR Brain; 2022 Apr; 145(2):655-669. PubMed ID: 34410345 [TBL] [Abstract][Full Text] [Related]
6. Beta-galactosidase-deficient mouse as an animal model for GM1-gangliosidosis. Matsuda J; Suzuki O; Oshima A; Ogura A; Noguchi Y; Yamamoto Y; Asano T; Takimoto K; Sukegawa K; Suzuki Y; Naiki M Glycoconj J; 1997 Sep; 14(6):729-36. PubMed ID: 9337086 [TBL] [Abstract][Full Text] [Related]
7. A GM1 gangliosidosis mutant mouse model exhibits activated microglia and disturbed autophagy. Liu S; Feng Y; Huang Y; Jiang X; Tang C; Tang F; Zeng C; Liu L Exp Biol Med (Maywood); 2021 Jun; 246(11):1330-1341. PubMed ID: 33583210 [TBL] [Abstract][Full Text] [Related]
8. GM1-gangliosidosis in a cross-bred dog confirmed by detection of GM1-ganglioside using electrospray ionisation-tandem mass spectrometry. Whitfield P; Johnson AW; Dunn KA; Delauche AJ; Winchester BG; Franklin RJ Acta Neuropathol; 2000 Oct; 100(4):409-14. PubMed ID: 10985700 [TBL] [Abstract][Full Text] [Related]
9. Development of lysosomal storage in mice with targeted disruption of the beta-galactosidase gene: a model of human G(M1)-gangliosidosis. Itoh M; Matsuda J; Suzuki O; Ogura A; Oshima A; Tai T; Suzuki Y; Takashima S Brain Dev; 2001 Oct; 23(6):379-84. PubMed ID: 11578847 [TBL] [Abstract][Full Text] [Related]
10. Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan. Weismann CM; Ferreira J; Keeler AM; Su Q; Qui L; Shaffer SA; Xu Z; Gao G; Sena-Esteves M Hum Mol Genet; 2015 Aug; 24(15):4353-64. PubMed ID: 25964428 [TBL] [Abstract][Full Text] [Related]
11. Type III (chronic) GM1-gangliosidosis. Histochemical and ultrastructural studies of rectal biopsy. Ushiyama M; Ikeda S; Nakayama J; Yanagisawa N; Hanyu N; Katsuyama T J Neurol Sci; 1985 Dec; 71(2-3):209-23. PubMed ID: 3936902 [TBL] [Abstract][Full Text] [Related]
12. Twenty-one novel mutations in the GLB1 gene identified in a large group of GM1-gangliosidosis and Morquio B patients: possible common origin for the prevalent p.R59H mutation among gypsies. Santamaria R; Chabás A; Coll MJ; Miranda CS; Vilageliu L; Grinberg D Hum Mutat; 2006 Oct; 27(10):1060. PubMed ID: 16941474 [TBL] [Abstract][Full Text] [Related]
13. GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis. Tessitore A; del P Martin M; Sano R; Ma Y; Mann L; Ingrassia A; Laywell ED; Steindler DA; Hendershot LM; d'Azzo A Mol Cell; 2004 Sep; 15(5):753-66. PubMed ID: 15350219 [TBL] [Abstract][Full Text] [Related]
14. Pathological findings of central nervous system, two GM1 gangliosidosis autopsy cases. Kara DÖ; Şahpaz A Turk J Pediatr; 2019; 61(6):953-957. PubMed ID: 32134593 [TBL] [Abstract][Full Text] [Related]
15. Novel Drug Candidates Improve Ganglioside Accumulation and Neural Dysfunction in GM1 Gangliosidosis Models with Autophagy Activation. Kajihara R; Numakawa T; Odaka H; Yaginuma Y; Fusaki N; Okumiya T; Furuya H; Inui S; Era T Stem Cell Reports; 2020 May; 14(5):909-923. PubMed ID: 32302553 [TBL] [Abstract][Full Text] [Related]
16. GM1 gangliosidosis in adults: clinical and molecular analysis of 16 Japanese patients. Yoshida K; Oshima A; Sakuraba H; Nakano T; Yanagisawa N; Inui K; Okada S; Uyama E; Namba R; Kondo K Ann Neurol; 1992 Mar; 31(3):328-32. PubMed ID: 1353343 [TBL] [Abstract][Full Text] [Related]
17. GM1-gangliosidosis in Alaskan huskies: clinical and pathologic findings. Müller G; Alldinger S; Moritz A; Zurbriggen A; Kirchhof N; Sewell A; Baumgärtner W Vet Pathol; 2001 May; 38(3):281-90. PubMed ID: 11355658 [TBL] [Abstract][Full Text] [Related]